[EN] SMALL MOLECULE ANTAGONISTS OF PF4<br/>[FR] ANTAGONISTES À PETITES MOLÉCULES DE PF4
申请人:NEW YORK BLOOD CENTER INC
公开号:WO2022073003A1
公开(公告)日:2022-04-07
The present application provides a compound of Formula (I) or a pharmaceutically acceptable salt thereof, wherein Y, R1, R2, R3and R4are described herein. The methods of using these compounds to inhibit tetramerization of PF4 and to treat the associated diseases and conditions, such as heparin-induced thrombocytopenia and thrombosis (HITT) and vaccine-induced immune thrombotic thrombocytopenia (VITT), methods of making these compounds, and pharmaceutical compositions containing these compounds are also disclosed.
A method of manufacturing an electrographic photoreceptor provided with a conductive substrate and a single-layered photosensitive layer is disclosed. The method includes: directly or indirectly applying a coating liquid for photosensitive layer formation onto the conductive substrate, the coating liquid containing a solvent, a charge generating agent, a binder resin, a hole transport material and an electron transport material; and removing part of the solvent to form the single-layered photosensitive layer. The solvent includes a first solvent as an alcohol with 1 to 3 carbon atoms and a second solvent as a solvent other than the first solvent. The binder resin includes a polyarylate resin as a polymerized product of monomers including a first monomer represented by General Formula (1) below and a second monomer represented by General Formula (2) below. The electron transport material includes a compound represented by General Formula (31), (32), (33) or (34) below.